Structural and functional differences between L-type calcium channels: Crucial issues for future selective targeting

Trends in Pharmacological Sciences

Volumn 32, Issue 6, 2011, Pages 366-375

  Zuccotti, Annalisa ^a   Clementi, Stefano ^b   Reinbothe, Thomas ^c   Torrente, Angelo ^d   Vandael, David H ^e   Pirone, Antonella ^a  

^a UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c LUND UNIVERSITY   (Sweden)

^d UNIV MONTPELLIER   (France)

^e Nanostructured Interfaces and Surfaces Centre of Excellence   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM ACTIVATED POTASSIUM CHANNEL; CALCIUM CALMODULIN DEPENDENT PROTEIN KINASE II; CALCIUM CHANNEL BLOCKING AGENT; CALCIUM CHANNEL L TYPE; CALMODULIN; CAV1.2 CALCIUM CHANNEL; CAV1.3 CALCIUM CHANNEL; DILTIAZEM; NIFEDIPINE; NIMODIPINE; STROMAL INTERACTION MOLECULE 1; UNCLASSIFIED DRUG; VERAPAMIL; VOLTAGE GATED CALCIUM CHANNEL;

ALTERNATIVE RNA SPLICING; AMINO ACID SEQUENCE; ANTIHYPERTENSIVE ACTIVITY; CARBOXY TERMINAL SEQUENCE; CHANNEL GATING; CHROMAFFIN CELL; DRUG DESIGN; DRUG MECHANISM; DRUG TARGETING; ENDOCRINE FUNCTION; GENETIC POLYMORPHISM; GENETIC VARIABILITY; HEART MUSCLE ISCHEMIA; HIPPOCAMPAL CA1 REGION; HUMAN; HYPERTENSION; INNER EAR; INSULIN RELEASE; MOLECULAR GENETICS; NERVE CELL PLASTICITY; NONHUMAN; PANCREAS ISLET BETA CELL; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN PROCESSING; PROTEIN PROTEIN INTERACTION; RETINA CELL; REVIEW; SENSORY NERVE CELL; SEQUENCE ALIGNMENT; SIGNAL TRANSDUCTION; SINUS NODE; STRUCTURE ACTIVITY RELATION; TISSUE DISTRIBUTION; TISSUE SPECIFICITY; TRANSCRIPTION REGULATION;

EID: 79957685488     PISSN: 01656147     EISSN: 18733735     Source Type: Journal    
DOI: 10.1016/j.tips.2011.02.012     Document Type: Review

References (94)

1. Catterall, W.A. et al. (2005) International Union of Pharmacology. XLVIII. Nomenclature and structure-function relationships of voltage-gated calcium channels. Pharmacol. Rev. 57, 411-425
2. Sinnegger-Brauns, M.J. et al. (2009) Expression and 1,4-dihydropyridine- binding properties of brain L-type calcium channel isoforms. Mol. Pharmacol. 75, 407-414
3. Striessnig, J. et al. (2010) Channelopathies in Cav1.1 Cav1. 3, and Cav1. 4 voltage-gated L-type Ca2+ channels. Pflugers Arch. 460, 361-374
4. Striessnig, J. and Koschak, A. (2008) Exploring the function and pharmacotherapeutic potential of voltage-gated Ca2+ channels with gene knockout models. Channels (Austin) 2, 233-251
5. Liao, P. and Soong, T.W. (2010) CaV1.2 channelopathies: from arrhythmias to autism, bipolar disorder, and immunodeficiency. Pflugers Arch. 460, 353-359
6. Baig, S.M. et al. (2011) Loss of Ca(v)1.3 (CACNA1D) function in a human channelopathy with bradycardia and congenital deafness. Nat. Neurosci. 14, 77-84
7. Bean, B.P. (2007) The action potential in mammalian central neurons. Nat. Rev. Neurosci. 8, 451-465
8. Chan, C.S. et al. (2007) 'Rejuvenation' protects neurons in mouse models of Parkinson's disease. Nature 447, 1081-1086
9. Puopolo, M. et al. (2007) Roles of subthreshold calcium current and sodium current in spontaneous firing of mouse midbrain dopamine neurons. J. Neurosci. 27, 645-656 (Pubitemid 46143768)
10. Mangoni, M.E. and Nargeot, J. (2008) Genesis and regulation of the heart automaticity. Physiol. Rev. 88, 919-982
11. Marcantoni, A. et al. (2010) Loss of Cav1.3 channels reveals the critical role of L-type and BK channel coupling in pacemaking mouse adrenal chromaffin cells. J. Neurosci. 30, 491-504
12. Marcotti, W. et al. (2003) Sodium and calcium currents shape action potentials in immature mouse inner hair cells. J. Physiol. 552, 743-761 (Pubitemid 37428417)
13. Singh, A. et al. (2008) Modulation of voltage- and Ca2+-dependent gating of CaV1.3 L-type calcium channels by alternative splicing of a C-terminal regulatory domain. J. Biol. Chem. 283, 20733-20744
14. Vandael, D.H. et al. (2010) Ca(v)1.3 and BK channels for timing and regulating cell firing. Mol. Neurobiol. 42, 185-198
15. Kollmar, R. et al. (1997) Hair cell-specific splicing of mRNA for the alpha1D subunit of voltage-gated Ca2+ channels in the chicken's cochlea. Proc. Natl. Acad. Sci. U.S.A. 94, 14889-14893
16. Liao, P. et al. (2004) Smooth muscle-selective alternatively spliced exon generates functional variation in Cav1.2 calcium channels. J. Biol. Chem. 279, 50329-50335
17. Dolphin, A.C. (2009) Calcium channel diversity: multiple roles of calcium channel subunits. Curr. Opin. Neurobiol. 19, 237-244
18. Hering, S. et al. (2008) Pore stability and gating in voltage-activated calcium channels. Channels (Austin) 2, 61-69
19. Kudrnac, M. et al. (2009) Coupled and independent contributions of residues in IS6 and IIS6 to activation gating of CaV1.2. J. Biol. Chem. 284, 12276-12284
20. Beyl, S. et al. (2011) Physicochemical properties of pore residues predict activation gating of Ca(V)1.2: a correlation mutation analysis. Pflugers Arch. 461, 53-63
21. Kim, J. et al. (2004) Identification of the components controlling inactivation of voltage-gated Ca2+ channels. Neuron 41, 745-754 (Pubitemid 38326837)
22. Tadross, M.R. et al. (2010) Molecular endpoints of Ca2+/calmodulin-and voltage-dependent inactivation of Ca(v)1.3 channels. J. Gen. Physiol. 135, 197-215
23. Hohaus, A. et al. (2005) Structural determinants of L-type channel activation in segment IIS6 revealed by a retinal disorder. J. Biol. Chem. 280, 38471-38477
24. Livneh, A. et al. (2006) A novel molecular inactivation determinant of voltage-gated CaV1.2 L-type Ca2+ channel. Neuroscience 139, 1275-1287
25. Nedergaard, S. et al. (1993) Nifedipine- and omega-conotoxin-sensitive Ca2+ conductances in guinea-pig substantia nigra pars compacta neurones. J. Physiol. 466, 727-747 (Pubitemid 23225251)
26. Mercuri, N.B. et al. (1994) Effects of dihydropyridine calcium antagonists on rat midbrain dopaminergic neurones. Br. J. Pharmacol. 113, 831-838
27. Takada, M. et al. (2001) Immunohistochemical localization of voltage-gated calcium channels in substantia nigra dopamine neurons. Eur. J. Neurosci. 13, 757-762
28. Zhang, H.Y. et al. (2010) Alternative splicing modulates diltiazem sensitivity of cardiac and vascular smooth muscle Ca(v)1.2 calcium channels. Br. J. Pharmacol. 160, 1631-1640
29. Namkung, Y. et al. (2001) Requirement for the L-type Ca(2+) channel alpha(1D) subunit in postnatal pancreatic beta cell generation. J. Clin. Invest. 108, 1015-1022
30. Misler, S. et al. (2005) Maintenance of stimulus-secretion coupling and single beta-cell function in cryopreserved-thawed human islets of Langerhans. Pflugers Arch. 450, 395-404 (Pubitemid 41380698)
31. Islam, M.S. (2010) Calcium signaling in the islets. Adv. Exp. Med. Biol. 654, 235-259
32. Braun, M. et al. (2008) Voltage-gated ion channels in human pancreatic beta-cells: electrophysiological characterization and role in insulin secretion. Diabetes 57, 1618-1628
33. Drews, G. et al. (2010) Electrophysiology of islet cells. Adv. Exp. Med. Biol. 654, 115-163
34. Vignali, S. et al. (2006) Characterization of voltage-dependent sodium and calcium channels in mouse pancreatic A- and B-cells. J. Physiol. 572, 691-706
35. Iwashima, Y. et al. (1993) Expression of calcium channel mRNAs in rat pancreatic islets and downregulation after glucose infusion. Diabetes 42, 948-955 (Pubitemid 23182159)
36. Seino, S. (1995) CACN4, the major alpha 1 subunit isoform of voltage-dependent calcium channels in pancreatic beta-cells: a minireview of current progress. Diabetes Res. Clin. Pract. 28 (Suppl.), S99-103
37. Schmitz, F. (2009) The making of synaptic ribbons: how they are built and what they do. Neuroscientist 15, 611-624
38. Rosa, J.M. et al. (2007) L-type calcium channels are preferentially coupled to endocytosis in bovine chromaffin cells. Biochem. Biophys. Res. Commun. 357, 834-839
39. Griesinger, C.B. et al. (2005) Fast vesicle replenishment allows indefatigable signalling at the first auditory synapse. Nature 435, 212-215 (Pubitemid 40685947)
40. Comunanza, V. et al. (2010) Ca(V)1. 3 as pacemaker channels in adrenal chromaffin cells: specific role on exo- and endocytosis? Channels (Austin) 4, 440-446
41. Barash, Y. et al. (2010) Deciphering the splicing code. Nature 465, 53-59
42. Calin-Jageman, I. and Lee, A. (2008) Ca(v)1 L-type Ca2+ channel signaling complexes in neurons. J. Neurochem. 105, 573-583
43. Tippens, A.L. et al. (2008) Ultrastructural evidence for pre- and postsynaptic localization of Cav1.2 L-type Ca2+ channels in the rat hippocampus. J. Comp. Neurol. 506, 569-583
44. Fourcaudot, E. et al. (2008) cAMP/PKA signaling and RIM1alpha mediate presynaptic LTP in the lateral amygdala. Proc. Natl. Acad. Sci. U.S.A. 105, 15130-15135
45. Lauri, S.E. et al. (2003) A role for Ca2+ stores in kainate receptor-dependent synaptic facilitation and LTP at mossy fiber synapses in the hippocampus. Neuron 39, 327-341 (Pubitemid 36897553)
46. Cohen, S. and Greenberg, M.E. (2008) Communication between the synapse and the nucleus in neuronal development, plasticity, and disease. Annu. Rev. Cell Dev. Biol. 24, 183-209
47. Halling, D.B. et al. (2006) Regulation of voltage-gated Ca2+ channels by calmodulin. Sci. STKE 2006, er1
48. Hudmon, A. et al. (2005) CaMKII tethers to L-type Ca2+ channels, establishing a local and dedicated integrator of Ca2+ signals for facilitation. J. Cell Biol. 171, 537-547 (Pubitemid 41586942)
49. Blaich, A. et al. (2010) Facilitation of murine cardiac L-type Ca(v)1.2 channel is modulated by calmodulin kinase II-dependent phosphorylation of S1512 and S1570. Proc. Natl. Acad. Sci. U.S.A. 107, 10285-10289
50. Jenkins, M.A. et al. (2010) Ca2+-dependent facilitation of Cav1.3 Ca2+ channels by densin and Ca2+/calmodulin-dependent protein kinase II. J. Neurosci. 30, 5125-5135
51. Gao, L. et al. (2006) Insulin-like growth factor-1 modulation of CaV1.3 calcium channels depends on Ca2+ release from IP3-sensitive stores and calcium/calmodulin kinase II phosphorylation of the alpha1 subunit EF hand. J. Neurosci. 26, 6259-6268
52. Zhang, H. et al. (2005) Association of CaV1.3 L-type calcium channels with Shank. J. Neurosci. 25, 1037-1049 (Pubitemid 40268946)
53. Zhang, H. et al. (2006) Ca1.2 and CaV1.3 neuronal L-type calcium channels: differential targeting and signaling to pCREB. Eur. J. Neurosci. 23, 2297-2310
54. Josephson, I.R. et al. (2010) Physiologic gating properties of unitary cardiac L-type Ca2+ channels. Biochem. Biophys. Res. Commun. 396, 763-766
55. Kolarow, R. et al. (2007) Postsynaptic secretion of BDNF and NT-3 from hippocampal neurons depends on calcium calmodulin kinase II signaling and proceeds via delayed fusion pore opening. J. Neurosci. 27, 10350-10364 (Pubitemid 47501996)
56. Kim, S. et al. (2007) Functional interaction of neuronal Cav1.3 L-type calcium channel with ryanodine receptor type 2 in the rat hippocampus. J. Biol. Chem. 282, 32877-32889
57. Ouardouz, M. et al. (2003) Depolarization-induced Ca2+ release in ischemic spinal cord white matter involves L-type Ca2+ channel activation of ryanodine receptors. Neuron 40, 53-63 (Pubitemid 37222463)
58. Barg, S. et al. (2002) A subset of 50 secretory granules in close contact with L-type Ca2+ channels accounts for first-phase insulin secretion in mouse beta-cells. Diabetes 51 (Suppl. 1), S74-82
59. Berridge, M.J. (2006) Calcium microdomains: organization and function. Cell Calcium 40, 405-412
60. Peters, J. et al. (2010) Induction of fear extinction with hippocampalinfralimbic BDNF. Science 328, 1288-1290
61. Moosmang, S. et al. (2005) Role of hippocampal Cav1.2 Ca2+ channels in NMDA receptor-independent synaptic plasticity and spatial memory. J. Neurosci. 25, 9883-9892 (Pubitemid 41528025)
62. Langwieser, N. et al. (2010) Homeostatic switch in hebbian plasticity and fear learning after sustained loss of Cav1.2 calcium channels. J. Neurosci. 30, 8367-8375
63. Dyachok, O. and Gylfe, E. (2004) Ca(2+)-induced Ca(2+) release via inositol 1,4,5-trisphosphate receptors is amplified by protein kinase A and triggers exocytosis in pancreatic beta-cells. J. Biol. Chem. 279, 45455-45461
64. Orchard, C.H. et al. (2009) The role of mammalian cardiac t-tubules in excitation-contraction coupling: experimental and computational approaches. Exp. Physiol. 94, 509-519
65. Copello, J.A. et al. (2007) Ca2+ entry-independent effects of L-type Ca2+ channel modulators on Ca2+ sparks in ventricular myocytes. Am. J. Physiol. Cell Physiol. 292, C2129-2140
66. Dulhunty, A.F. et al. (2004) Peptide fragments of the dihydropyridine receptor can modulate cardiac ryanodine receptor channel activity and sarcoplasmic reticulum Ca2+ release. Biochem. J. 379, 161-172 (Pubitemid 38491371)
67. Wielowieyski, P.A. et al. (2001) Alternative splicing in intracellular loop connecting domains II and III of the alpha 1 subunit of Cav1.2 Ca2+ channels predicts two-domain polypeptides with unique Cterminal tails. J. Biol. Chem. 276, 1398-1406
68. Wang, Y. et al. (2010) The calcium store sensor STIM1, reciprocally controls Orai and CaV1. 2 channels. Science 330, 105-109
69. Park, C.Y. et al. (2010) The CRAC channel activator STIM1 binds and inhibits L-type voltage-gated calcium channels. Science 330, 101-105
70. Berrout, J. and Isokawa, M. (2009) Homeostatic and stimulus-induced coupling of the L-type Ca2+ channel to the ryanodine receptor in the hippocampal neuron in slices. Cell Calcium 46, 30-38
71. Dreze, M. et al. (2010) High-quality binary interactome mapping. Methods Enzymol. 470, 281-315
72. Fakler, B. and Adelman, J.P. (2008) Control of K(Ca) channels by calcium nano/microdomains. Neuron 59, 873-881
73. Lu, L. et al. (2007) Molecular coupling of a Ca2+-activated K+ channel to L-type Ca2+ channels via alpha-actinin2. Circ. Res. 100, 112-120
74. Brandt, A. et al. (2003) CaV1.3 channels are essential for development and presynaptic activity of cochlear inner hair cells. J. Neurosci. 23, 10832-10840 (Pubitemid 37499690)
75. Belle, M.D. et al. (2009) Daily electrical silencing in the mammalian circadian clock. Science 326, 281-284
76. Sun, W. et al. (1992) Mapping of a human brain voltage-gated calcium channel to human chromosome 12p13-pter. Genomics 14, 1092-1094 (Pubitemid 23053051)
77. Seino, S. et al. (1992) Assignment of the gene encoding the alpha 1 subunit of the neuroendocrine/brain-type calcium channel (CACNL1A2) to human chromosome 3, band p14.3. Genomics 13, 1375-1377
78. Splawski, I. et al. (2004) Ca(V)1.2 calcium channel dysfunction causes a multisystem disorder including arrhythmia and autism. Cell 119, 19-31 (Pubitemid 39349317)
79. Splawski, I. et al. (2005) Severe arrhythmia disorder caused by cardiac L-type calcium channel mutations. Proc. Natl. Acad. Sci. U.S.A. 102, 8089-8096 discussion 8086-8088
80. Beitelshees, A.L. et al. (2009) CACNA1C gene polymorphisms, cardiovascular disease outcomes, and treatment response. Circ. Cardiovasc. Genet. 2, 362-370
81. Pepine, C.J. et al. (2003) A calcium antagonist vs a non-calcium antagonist hypertension treatment strategy for patients with coronary artery disease. The International Verapamil-Trandolapril Study (INVEST): a randomized controlled trial. JAMA 290, 2805-2816
82. Zhao, Y. et al. (2009) Effects of CYP3A5, MDR1 and CACNA1C polymorphisms on the oral disposition and response of nimodipine in a Chinese cohort. Eur. J. Clin. Pharmacol. 65, 579-584
83. Bremer, T. et al. (2006) CACNA1C polymorphisms are associated with the efficacy of calcium channel blockers in the treatment of hypertension. Pharmacogenomics 7, 271-279
84. Kamide, K. et al. (2009) Genetic polymorphisms of L-type calcium channel alpha1C and alpha1D subunit genes are associated with sensitivity to the antihypertensive effects of L-type dihydropyridine calcium-channel blockers. Circ. J. 73, 732-740
85. Green, E.K. et al. (2010) The bipolar disorder risk allele at CACNA1C also confers risk of recurrent major depression and of schizophrenia. Mol. Psychiatry 15, 1016-1022
86. Casamassima, F. et al. (2010) L-type calcium channels, psychiatric disorders: A brief review. Am. J. Med. Genet. B: Neuropsychiatr. Genet. 153B, 1373-1390
87. Lavebratt, C. et al. (2010) Variations in FKBP5 and BDNF genes are suggestively associated with depression in a Swedish population-based cohort. J. Affect. Disord. 125, 249-255
88. Schrattenholz, A. et al. (2010) Systems biology approaches and tools for analysis of interactomes and multi-target drugs. Methods Mol. Biol. 662, 29-58
89. Valadkhan, S. and Jaladat, Y. (2010) The spliceosomal proteome: at the heart of the largest cellular ribonucleoprotein machine. Proteomics 10, 4128-4141
90. Lievens, S. et al. (2010) Large-scale protein interactome mapping: strategies and opportunities. Expert Rev. Proteomics 7, 679-690
91. Mitterdorfer, J. et al. (1998) Molecular basis of drug interaction with L-type Ca2+ channels. J. Bioenerg. Biomembr. 30, 319-334
92. Lacinova, L. (2005) Voltage-dependent calcium channels. Gen. Physiol. Biophys. 24 (Suppl. 1), 1-78
93. McDonough, S.I. et al. (2005) FPL 64176 modification of Ca(V)1.2 L-type calcium channels: dissociation of effects on ionic current and gating current. Biophys. J. 88, 211-223
94. Liao, P. et al. (2005) Splicing for alternative structures of Cav1.2 Ca2+ channels in cardiac and smooth muscles. Cardiovasc. Res. 68, 197-203